THE APPROVAL OF VEDOLIZUMAB FOR THE MANAGEMENT OF INFLAMMATORY BOWEL DISEASES IN BRAZIL: the beginning of a new biological era

AUTOR(ES)

KOTZE, Paulo Gustavo, DAMIÃO, Aderson Omar Mourão Cintra, MORAES, Antonio Carlos

FONTE

Arq. Gastroenterol.

DATA DE PUBLICAÇÃO

2016-03

RESUMO

Documentos Relacionados

• VEDOLIZUMAB IN THE MANAGEMENT OF INFLAMMATORY BOWEL DISEASES: A BRAZILIAN OBSERVATIONAL MULTICENTRIC STUDY
• Inflammatory Bowel Diseases
• Epidemiological profile of inflammatory bowel disease in Caxias do Sul, Brazil: a cross-sectional study
• A role for proteinase-activated receptor–1 in inflammatory bowel diseases
• INCIDENCE, PREVALENCE, AND EPIDEMIOLOGICAL CHARACTERISTICS OF INFLAMMATORY BOWEL DISEASES IN THE STATE OF PARANÁ IN SOUTHERN BRAZIL